Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Is Gilead Sciences Stock Outperforming the S&P 500?

With a market cap of around $136 billion, Gilead Sciences, Inc. (GILD) is a biopharmaceutical company. The Foster City, California-located company discovers, develops, and commercializes medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, COVID-19, cancer, and inflammation. 

Companies worth $10 billion or more are generally described as “large-cap stocks”, and Gilead Sciences fits this criterion perfectly. The company continues to expand its oncology pipeline through strategic acquisitions and partnerships, while maintaining a strong commitment to scientific research and global health impact.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.